Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular cobalamin transport and metabolism pathway encompasses the series of proteins responsible for the uptake, intracellular trafficking, and enzymatic conversion of Vitamin B12 into its active cofactors. Key components include the CD320 receptor for cellular entry, the MMACHC and MMADHC proteins for intracellular processing, and the enzymes Methionine synthase (MTR) and Methylmalonyl-CoA mutase (MUT). These targets are essential for DNA synthesis and the maintenance of the nervous system, as they facilitate the conversion of homocysteine to methionine and methylmalonyl-CoA to succinyl-CoA. Genetic mutations in any of these components lead to serious metabolic disorders such as methylmalonic acidemia and homocystinuria. Pharmacological intervention typically involves high-dose administration of various cobalamin forms to overcome transport inefficiencies or enzymatic blocks.
Supplementation of cobalamin derivatives to bypass transport defects or provide substrates for deficient enzymes (MTR, MUT).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular cobalamin transport and metabolism pathway (Cobalamin pathway).